About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics and Mylan Agree Settlement

December 19, 2018

Click here to read more

Post navigation

Voluntary Withdrawal from OTCQX

2019 Annual General Meeting Results

Related Posts

Phosphagenics Announces Equity Raising

September 26, 2017

Phosphagenics Announces Successful Results from its Phase 2 TPM®/Tretinoin Gel Study on Acne Patients

October 7, 2014

Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer

January 14, 2015

Recent Posts

$5.06m Placement Complete
February 9, 2021
Interview with Peter Switzer
January 19, 2021
Observational study testing enhanced CBD formulation
December 22, 2020

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.